Rare diseases
Investigational molecules
Locations
378 conditions with trials, the busiest first
838 trials across Europe, recruiting first
Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
AustriaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
AustriaFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
FranceA study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.
GermanyA study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure
BulgariaEvaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers
CzechiaBioequivalence Study of Ticagrelor 90 mg Capsules (PG402) vs Tablets in Healthy Volunteers for Prevention of Acute Coronary Syndrome
PolandA study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis
BelgiumBioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms
GermanyA study comparing the absorption of rosuvastatin, amlodipine, and ramipril in healthy men and women.
CzechiaPharmacokinetics, Pharmacodynamics and Safety of Inhaled and Intravenous d,l‑lysine acetylsalicylate in Healthy Adults with Migraine
GermanyA study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.
SpainThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
